Patents by Inventor David W. Potter

David W. Potter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240121198
    Abstract: Embodiments provide systems and techniques for testing the functionality of a network architecture having multiple redundant internet protocol (IP) networks. An example system includes a first IP network having a first network device, and a second IP network having a second network device. The system also includes a computing device coupled to the first IP network via the first network device and to the second IP network via the second network device. The first network device is configured to selectively forward first packet(s) of the IP media traffic flow to the computing device when the first packet(s) satisfies a first predetermined condition. The second network device is configured to selectively forward second packet(s) of the IP media traffic flow to the computing device when the second packet(s) satisfies a second predetermined condition.
    Type: Application
    Filed: October 7, 2022
    Publication date: April 11, 2024
    Inventors: Michael J. STREIN, Guy W. BEVERLIN, Nigel BROWNETT, Eric F. POHL, David E. POTTER
  • Patent number: 9359289
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising; the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: June 7, 2016
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Publication number: 20160039750
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Application
    Filed: August 4, 2015
    Publication date: February 11, 2016
    Applicant: Intrexon Corporation
    Inventors: Robert Eugene HORMANN, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Patent number: 9255273
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: February 9, 2016
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Patent number: 9169210
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: October 27, 2015
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Publication number: 20150240244
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Application
    Filed: August 20, 2007
    Publication date: August 27, 2015
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Patent number: 9102648
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: August 11, 2015
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Publication number: 20140144356
    Abstract: Systems and processes for processing sludge and other natural waste are provided. In one example, the sludge or natural waste may be dried into a powder using high-temperature gas to absorb moisture from the sludge, causing the high-temperature gas to become an at least partially saturated gas. The at least partially saturated gas may pass through a scrubber before being heated in an air-heater and used in the moisture absorption process. The heat for the air-heater may be provided by a burner operable to burn the dried powder obtained from the sludge. The heated gas may be used to pre-heat the saturated gas and may be used to dry additional sludge.
    Type: Application
    Filed: September 15, 2011
    Publication date: May 29, 2014
    Applicant: Gate 5 Energy Partners, Inc.
    Inventors: David W. Potter, Patrick Potter, John J. Potter, Steven Delson, Lynn G. Holton
  • Publication number: 20140045903
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Application
    Filed: July 30, 2013
    Publication date: February 13, 2014
    Applicant: Intrexon Corporation
    Inventors: Robert Eugene HORMANN, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Patent number: 8524948
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: September 3, 2013
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Publication number: 20130040389
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Application
    Filed: September 5, 2012
    Publication date: February 14, 2013
    Applicant: Intrexon Coporation
    Inventors: Robert Eugene HORMANN, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Publication number: 20130035487
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Application
    Filed: September 5, 2012
    Publication date: February 7, 2013
    Applicant: Intrexon Corporation
    Inventors: Robert Eugene HORMANN, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Publication number: 20120046322
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Application
    Filed: September 23, 2011
    Publication date: February 23, 2012
    Applicant: Intrexon Corporation
    Inventors: Robert Eugene HORMANN, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Patent number: 7563928
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: July 21, 2009
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Patent number: 7456315
    Abstract: The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: November 25, 2008
    Assignee: Intrexon Corporation
    Inventors: Robert Eugene Hormann, David W. Potter, Orestes Chortyk, Colin M. Tice, Glenn Richard Carlson, Andrew Meyer, Thomas R. Opie
  • Patent number: 6725305
    Abstract: The present invention is a method and apparatus for dynamically holding valid data logic levels on a bus by taking advantage of the inherent storage capacity of the bus. The bus speed is increased by eliminating the use of active bus keepers and null cycles. Instead, a two phase clock is used, the bus drivers drive data onto the bus during the first phase of the clock and are turned off at the beginning of the second phase of the bus clock. The receiving device latches the data during the second phase of the bus clock. Accordingly, there is no need for a null cycle or a bus keeper circuit, yet there is no bus contention between consecutive drivers nor is there a floating node condition.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: April 20, 2004
    Assignee: Agere Systems Inc.
    Inventors: Hyun Lee, David W. Potter, Lai Q. Pham
  • Patent number: 6611893
    Abstract: A method and apparatus for arbitrating access to a bus such that the bus can operate at a variable data rate, that rate being the rate of the slower of the two devices communicating over the bus. The smart arbiter in accordance with the invention has knowledge of the speed of the devices that use the bus and grants access in an order and at a rate based on that information. The smart arbiter can intersperse grants such that data transfers between multiple pairs of transmitting and receiving devices that are not independently utilizing the maximum bandwidth capabilities of the bus can overlap. Thus, if one pair of devices are exchanging multiple consecutive words (or other units of data) at a rate slower than the maximum rate of the bus, another pair of devices can use some of the bus clock cycles between the transfer of words of the first device pair, for transfers of words between the second device pair.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: August 26, 2003
    Assignee: Agere Systems Inc.
    Inventors: Hyun Lee, David W. Potter
  • Patent number: 6484267
    Abstract: The present invention comprises a clocked bus keeper circuit that does not drive the bus during the first half of a clock cycle and then holds the value driven onto the bus during the first half of the clock cycle for the second half of the clock cycle. Accordingly, true data drivers on the bus drive the bus during the first half of the clock cycle without the need to overcome the value driven by the bus keeper, but during the second half of the clock cycle, the bus keeper holds the data driven during the first half of the clock cycle. In this manner, there is no bus contention between the true bus data drivers and the bus keeper.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: November 19, 2002
    Assignee: Agere Systems Inc.
    Inventors: Hyun Lee, David W. Potter
  • Patent number: 5170477
    Abstract: A system for transferring a plurality of data items (bytes) between a source device and a destination device. The system loads data items from the source device into a register so as to align the data items with the storage locations of the destination device, transfers the aligned data items to the destination device, rolls-down, in sequence, any remaining data items in the register to least significant storage locations thereof; loads a full data word, which includes a predetermined number N of data items, from the source device into the register starting with the most significant storage location of the register containing a data item; and transfers N or fewer data items stored in the register, starting from the least significant storage location of the register to the destination device.
    Type: Grant
    Filed: October 31, 1989
    Date of Patent: December 8, 1992
    Assignee: IBM Corporation
    Inventors: David W. Potter, Ralph J. Scaccia